Dual-Channel Detection of Breast Cancer Biomarkers CA15-3 and CEA in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor
Hang Li,Shuai Wang,Xiaosong Li,Cong Cheng,Xiping Shen,Tong Wang
DOI: https://doi.org/10.2147/ijn.s391234
IF: 7.033
2022-12-13
International Journal of Nanomedicine
Abstract:Hang Li, 1, &ast Shuai Wang, 2, &ast Xiaosong Li, 1 Cong Cheng, 3 Xiping Shen, 1 Tong Wang 3 1 Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, People's Republic of China; 2 Department of General Surgery, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu Province, People's Republic of China; 3 Department of General Surgery, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, Jiangsu Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiping Shen, Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, 215000, People's Republic of China, Tel +86-512-82881248, Email Tong Wang, Department of General Surgery, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, Jiangsu Province, 214000, People's Republic of China, Tel +86-510-82700778, Email Background: Breast cancer (BC) is the most common malignant tumors and the leading cause of cancer deaths among women. The early diagnosis and treatment of BC are effective measures that can increase survival rates and reduce mortality. Carbohydrate antigens 15– 3 (CA15-3) and carcinoma embryonic antigens (CEA) have been regarded as the most two valuable tumor markers of BC. The combined detection of CA15-3 and CEA could improve the sensitivity and accuracy of early diagnosis for BC. Methods: The multi-channel double-gate silicon nanowire field effect transistor (SiNW-FET) biosensors were fabricated by using the top-down semiconductor manufacturing technology. By surface modification of the different SiNW surfaces with monoclonal CA15-3 and CEA antibodies separately, the prepared SiNW-FET was processed into biosensor for dual-channel detection of CA15-3 and CEA. Results: The prepared SiNW-FET biosensors were proved to have high sensitivity and specificity for the dual-channel detection of CA15-3 and CEA, and the detection limit is as low as 0.1U/mL CA15-3 and 0.01 ng/mL CEA. Moreover, the SiNW-FET biosensors were able to detect CA15-3 and CEA in serum by connecting a miniature hemodialyzer. Conclusion: The present study reported a SiNW-FET biosensor for dual-channel detection of breast cancer biomarkers CA15-3 and CEA in serum, which has potential clinical application value for the early diagnosis and curative effect observation of BC. Keywords: breast cancer, dual-channel detection, dialysis, silicon nanowire field effect transistor, carbohydrate antigens 15-3, carcinoma embryonic antigens Breast cancer (BC) is the most common malignant tumors and the leading cause of cancer deaths among women. 1 Moreover, the incidence of BC in the world is continuously increasing each year, and it increases with age. 2,3 BC is usually in the mid and late stage when it is diagnosed definitely because of the insidious and atypical symptoms at the early stage of BC. 4 The early diagnosis and treatment of BC are effective measures that can increase survival rates and reduce mortality. 1,5 At present, the main methods to screen and early diagnose BC include imaging examinations, breast biopsy and detection of serum tumor markers. 6 Imaging examinations such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron-emission tomography (PET) and ultrasound have limited value in the early diagnosis of BC, and also rely on expensive testing equipment. 7 Breast biopsy is widely acknowledged as the gold standard for the early diagnosis of BC. But, breast biopsy is an invasive test, which will cause varying degrees of pain for subjects and not suitable for mass screening. Presently, besides imaging examinations and breast biopsy, the detection of serum tumor markers has become a new kind of important method used in early diagnosis of BC, and also is help to improve the detection rate and diagnosis accuracy. 8 Carbohydrate antigens 15–3 (CA15-3) and carcinoma embryonic antigens (CEA) have been regarded as the most two valuable tumor markers for the early diagnosis and curative effect observation of BC based on their high expression were closely correlated with BC occurrence. 9 It has been shown that the detection of single tumor marker was inadequate for cancer diagnosis due to limited sensitivity and specificity, and the combined detection of CA15-3 and CEA could provide more information for clinical decision-making. 10 Currently, the detection means for CA15-3 and CEA consist mainly of enzyme-linked immunosorbent assay (ELISA), electrochemical immunoassay (ECIA), el -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology